Women with a genetic predisposition to chronic hepatitis B (CHB) infection had a 15% higher risk of developing pre-eclampsia (OR = 1.15). These women also had a 56% higher risk of developing eclampsia ...

Severe headaches appear as warning signs before more serious complications develop. These headaches differ from typical ...

Pregnant mothers experiencing high blood pressure may have to worry about another potential health risk to their children, ...

Toronto’s first heat wave of the summer is coming. Heat is a “silent killer” as it masquerades as many other health problems, ...

A new smart watch which uses machine learning to monitor for the most dangerous kinds of epileptic seizures has been approved by the FDA. Cambridge, Massachusetts based Empatica is the company ...

People with a form of severe epilepsy will now be able to get NHS access to a new drug from UCB, Fintepla, that could significantly reduce their seizures. The NHS will fund Fintepla (fenfluramine ...

Neuroscience specialist Lundbeck has agreed to buy Longboard Pharmaceuticals for $2.6 billion, expanding its pipeline with an epilepsy drug tipped as a future blockbuster. The Danish drugmaker has ...

Epilepsy refers to a group of neurological disorders of varying aetiology, characterized by recurrent brain dysfunction that result from sudden excessive and disordered neuronal discharge. These ...

Shares in UCB slid this morning after the Belgian company announced its refractory epilepsy drug candidate padsevonil had failed a phase 2b trial. The ARISE trial of padsevonil did not reach ...